VOYA Investment Management’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.3K | Hold |
25,097
| – | – | ﹤0.01% | 2510 |
|
|
2025
Q1 | $75K | Sell |
25,097
-4,245
| -14% | -$12.7K | ﹤0.01% | 2482 |
|
|
2024
Q4 | $98.3K | Sell |
29,342
-1,632
| -5% | -$5.47K | ﹤0.01% | 2580 |
|
|
2024
Q3 | $104K | Sell |
30,974
-339
| -1% | -$1.14K | ﹤0.01% | 2655 |
|
|
2024
Q2 | $104K | Buy |
31,313
+2,766
| +10% | +$9.16K | ﹤0.01% | 2658 |
|
|
2024
Q1 | $115K | Sell |
28,547
-4,739
| -14% | -$19.1K | ﹤0.01% | 2601 |
|
|
2023
Q4 | $102K | Hold |
33,286
| – | – | ﹤0.01% | 2753 |
|
|
2023
Q3 | $99.9K | Sell |
33,286
-29,552
| -47% | -$88.7K | ﹤0.01% | 2733 |
|
|
2023
Q2 | $235K | Buy |
62,838
+961
| +2% | +$3.59K | ﹤0.01% | 2504 |
|
|
2023
Q1 | $207K | Buy |
61,877
+7,093
| +13% | +$23.8K | ﹤0.01% | 2516 |
|
|
2022
Q4 | $264K | Buy |
54,784
+24,327
| +80% | +$117K | ﹤0.01% | 2418 |
|
|
2022
Q3 | $173K | Buy |
30,457
+2,072
| +7% | +$11.8K | ﹤0.01% | 2646 |
|
|
2022
Q2 | $202K | Buy |
28,385
+3,636
| +15% | +$25.9K | ﹤0.01% | 2390 |
|
|
2022
Q1 | $179K | Hold |
24,749
| – | – | ﹤0.01% | 2394 |
|
|
2021
Q4 | $221K | Sell |
24,749
-725
| -3% | -$6.47K | ﹤0.01% | 2452 |
|
|
2021
Q3 | $893K | Hold |
25,474
| – | – | ﹤0.01% | 1647 |
|
|
2021
Q2 | $547K | Buy |
25,474
+19,120
| +301% | +$411K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $392K | Buy |
6,354
+1,526
| +32% | +$94.1K | ﹤0.01% | 2162 |
|
|
2020
Q4 | $202K | Buy |
+4,828
| New | +$202K | ﹤0.01% | 2418 |
|